e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Murine models of lung immunology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of secreted phospholipase A
2
group IID, IIE, and IIF-deficiency on allergen-driven asthma phenotype
W. Henderson, J. Bollinger, J. Xue, Y. T. Tien, M. Gelb (Seattle, United States Of America)
Source:
Annual Congress 2013 –Murine models of lung immunology
Session:
Murine models of lung immunology
Session type:
Poster Discussion
Number:
1567
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
W. Henderson, J. Bollinger, J. Xue, Y. T. Tien, M. Gelb (Seattle, United States Of America). Effect of secreted phospholipase A
2
group IID, IIE, and IIF-deficiency on allergen-driven asthma phenotype. Eur Respir J 2013; 42: Suppl. 57, 1567
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Characterization of an endogenous Th17-cell generation during sensitization in the murine lung
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Vitamin C inhibits the diisocyanate-induced lung inflammatory response in mice
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma (AIA)
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
The homologous IL-17 cytokines A and F differentially regulate allergic asthma in murine models
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Characterisation of a steroid-insensitive severe asthma model
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014
Transient receptor potential channels in a mouse model of isocyanate-induced airway hyperresponsiveness
Source: International Congress 2014 – Mechanistic murine studies of asthma and lung inflammation
Year: 2014
The effect of different PV extracts in the treatment of asthma in an animal model
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
IL33 and TSLP involvements in influenza-induced exacerbation in a murine model of chronic asthma
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
IL-25 induces airways angiogenesis and expression of multiple angiogenic factors in a murine asthma model
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
IL-13 in a mouse model of chemical-induced airway hyperresponsiveness
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
Aquaporin-3 potentiates murine asthma through mediating T-cell trafficking and chemokine production
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Immunomodulatory role of IL-37 in asthma pathogenesis
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
The immunomodulatory activity of protein S protects against allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
IL-4 polymorphisms in intrinsic and extrinsic asthma in a Greek population
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
Dose-dependent differential effects of thrombin in allergic bronchial asthma
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Standardization of a murine model of asthma due to soybean inhalation
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept